Marie Schwinn is a Senior Research Scientist in the R&D department at Promega Corporation, where she develops predictive cell models for use in basic research and drug discovery. She specializes in applying genome-editing techniques to engineer cells for studying protein abundance, interactions, and localization in a native biological context. Dr. Schwinn holds a doctorate in Biochemistry from the University of Wisconsin–Madison.